急性损伤中的血栓炎症:感染、热射病与创伤
综述阐述急性感染、热射病与创伤中凝血与炎症互作导致血栓炎症和微血栓形成,参与多器官功能障碍;脓毒症中肝素、抗凝血酶或血栓调节蛋白降低死亡率尚未获确证,血栓炎症可能为未来临床研究提供潜在治疗靶点。
要点
- 急性感染、热射病与创伤中凝血与炎症互作驱动血栓炎症和微血栓形成,参与多器官功能障碍。
- 凝血酶在协调血栓形成与炎症中起核心作用,长期被视为脓毒症的潜在治疗靶点。
- 肝素预防静脉血栓栓塞是COVID-19标准管理的一部分,也可能减轻血栓后遗所致器官功能障碍。
核心结论
- 血栓炎症是感染、热射病与创伤等危重症的重要病理生理机制,可能为未来临床研究提供潜在治疗靶点。
研究设计与样本
- 综述,围绕急性感染、热射病与创伤等急性损伤中血栓炎症的病理机制与治疗证据进行汇总。
主要发现
- 急性感染后凝血激活与炎症激活相互关联,导致血栓炎症和微血栓形成,参与多器官功能障碍。
- 脓毒症是最常见的基础疾病且已被广泛研究,COVID-19大流行进一步阐明了血栓炎症起关键作用的疾病病理机制。
- 血栓炎症过程中,单核细胞、中性粒细胞、血小板和内皮细胞损伤,伴凝血与补体激活。
- 凝血酶在协调血栓形成与炎症中起核心作用,长期被视为脓毒症的潜在治疗靶点。
- 肝素预防静脉血栓栓塞是COVID-19标准管理的一部分,也可能减轻血栓后遗所致器官功能障碍;而肝素、抗凝血酶或血栓调节蛋白抗凝降低脓毒症死亡率的效果尚未获确证。
关键数值与推荐
- 肝素预防静脉血栓栓塞为COVID-19标准管理的一部分。
- 肝素、抗凝血酶或血栓调节蛋白抗凝降低脓毒症死亡率的效果尚未获确证。
- 热射病、创伤和缺血/再灌注损伤中血栓炎症也被报告为重要病理生理机制。
临床怎么用
- 肝素预防静脉血栓栓塞是COVID-19标准管理的一部分,并可能减轻血栓后遗所致器官功能障碍。
- 脓毒症中肝素、抗凝血酶或血栓调节蛋白抗凝降低死亡率尚未获确证。
- 血栓炎症可能为热射病、创伤和缺血/再灌注损伤等危重症的未来临床研究提供潜在治疗靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tissue microcirculation is essential for the maintenance of organ homeostasis. Following acute infections, activation of coagulation and inflammation, which are critical interconnected responses, lead to thromboinflammation and microthrombosis, thereby contributing to multiorgan dysfunction. Sepsis is the most common underlying disease and has been extensively studied. However, the COVID-19 pandemic further illustrated the pathomechanisms of diseases in which thromboinflammation plays a critical role. During thromboinflammation, injury to monocytes, neutrophils, platelets, and endothelial cells, along with coagulation and complement activation, was further characterized. Thrombin is pivotal in orchestrating thrombosis and inflammation and has long been considered a potential therapeutic target in sepsis. Although thromboprophylaxis for venous thromboembolism with heparins is part of standard management for COVID-19, it also potentially attenuates organ dysfunction due to thrombotic sequela. In contrast, the effectiveness of anticoagulation with heparin, antithrombin, or thrombomodulin to reduce mortality has not conclusively been proven in sepsis. Nonetheless, thromboinflammation has also been reported as an important pathophysiologic mechanism in other critical illnesses, including heatstroke, trauma, and ischemia/reperfusion injury, and may provide a potential therapeutic target for future clinical studies.
引用
- Iba T, Helms J, Levi M, et al. Thromboinflammation in acute injury: infections, heatstroke, and trauma. J Thromb Haemost. 2023. PMID: 37541590. doi:10.1016/j.jtha.2023.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。